Sundar PichaiSundar Pichai earned $164M in 2023

Patrick J. McEnany has been at the helm of Catalyst Pharmaceutical for nearly a decade, serving as CEO since 2014. With a focus in the pharmaceutical field, he has guided the company through significant growth, aligning executive pay with company...

Quick Links
C

Patrick J. McEnany

Ex-CEO of Catalyst Pharmaceutical

Education

Not specified

Sector of Economy

Healthcare

Born

September 12, 1944 - 80 years ago

CEO of Catalyst Pharmaceutical for

9 years 7 months (May 2014 - Dec 2023)

Previous Experience

Chairman and CEO of Catalyst Pharmaceuticals, Inc.

Rivals

Competitors/colleagues of Patrick J. McEnany

Holdings

See how much did Patrick J. McEnany make over time.

Patrick J. McEnany's stock holdings in Catalyst Pharmaceutical have seen impressive growth over the years, reflecting his confidence in the company. Notably, over the course of 2021 to 2022, his holdings skyrocketed from around $20.40 million to a peak of...

No data yet.

No data yet.

Charitable Transactions

CPRX

50,100 shares

CPRX

Recent Charitable Transactions

CPRX

5,100 shares

CPRX

Aug 22, 2024

Charity

CPRX

45,000 shares

CPRX

Aug 15, 2024

Charity

Insider Trading

See recent insider trades of Patrick J. McEnany.

CPRX

5,100 shares

CPRX

Aug 22, 2024

Charity

CPRX

45,000 shares

CPRX

Aug 15, 2024

Charity

Compensation History

See how much did Patrick J. McEnany make over time.

In 2023, Patrick J. McEnany's total compensation at Catalyst Pharmaceutical reached $1 million. His salary accounted for half of this at $500,000, with a performance-related bonus of $150,000. He also received $300,000 in vested stock, a sign of previous investments paying off. The company’s approach to compensation is designed to link executive pay directly to measurable performance, which includes revenue growth and operational efficiency. This aligns the incentives of key executives with the overall success of the company, ensuring that McEnany's goals were directly tied to shareholder value. His total compensation fluctuated over the years, with peaks reaching over $2 million in 2021, reflecting the company's impressive financial performance during his leadership years. His unique approach of rewarding based on strict performance metrics highlights a practical strategy geared towards motivating high performance within the leadership team.

Year

2023

Total Compensation

$1.00M

Salary

$500.00K

Board Justification

The compensation philosophy aligns with company performance and peer benchmarking to ensure competitive pay while retaining key talent.

Bonus

$150.00K

Board Justification

The bonus is based on the achievement of specific performance metrics set by the board, including revenue growth and operational efficiency, paid out in cash in 2023.

Other

$50.00K

Board Justification

Other compensation includes health benefits and retirement contributions paid in 2023.

Restricted Stock

$300.00K(20K common stock)

Board Justification

The vested stock represents shares that were granted in previous years and vested in 2023, paid out as common stock.

Performance Metrics

Performance metrics include revenue targets, operational efficiency, and overall company performance relative to peers.

Other Catalyst Pharmaceutical CEOs

Here are other CEOs of Catalyst Pharmaceutical